Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer′s disease?

Glycogen and amyloid-beta: key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer′s disease?

Bibliographic Details
Main Authors:	Brittany Bass, Sarah Upson, Kamolika Roy, Emily L Montgomery, Tuula O Jalonen, Ian V.J. Murray
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2015-01-01
Series:	Neural Regeneration Research
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2015;volume=10;issue=7;spage=1023;epage=1025;aulast=Bass

Similar Items

The Difference of Lower Urinary Tract Symptoms Between Sympathetic Hyperactive and Hypoactive Men
by: Dong Geun Oh, et al.
Published: (2013-03-01)

Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease
by: B. DaRocha-Souto, et al.
Published: (2012-01-01)

Impaired hepatic amyloid-beta degradation in Alzheimer's disease.
by: Chera L Maarouf, et al.
Published: (2018-01-01)

Circular RNA Encoded Amyloid Beta peptides—A Novel Putative Player in Alzheimer’s Disease
by: Dingding Mo, et al.
Published: (2020-09-01)

Amyloid beta and Alzheimer’s Disease: The role of neprilysin-2 in amyloid-beta clearance
by: Robert eMarr, et al.
Published: (2014-08-01)

Amyloid Beta in Aging and Alzheimer’s Disease
by: Ujala Sehar, et al.
Published: (2022-10-01)

BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01)

Effects of transmitters and amyloid-beta peptide on calcium signals in rat cortical astrocytes: Fura-2AM measurements and stochastic model simulations.
by: Eeva Toivari, et al.
Published: (2011-01-01)

Bremelanotide for Hypoactive Sexual Desire Disorder
by: T. S. Sathyanarayana Rao, et al.
Published: (2020-01-01)

Amyloid Beta and MicroRNAs in Alzheimer’s Disease
by: Nnana Amakiri, et al.
Published: (2019-05-01)

Editorial on, Amyloid-beta clearance in Alzheimer’s disease.
by: Robert eMarr
Published: (2014-11-01)

Reduced sleep-like quiescence in both hyperactive and hypoactive mutants of the Galphaq Gene egl-30 during lethargus in Caenorhabditis elegans.
by: Juliane Schwarz, et al.
Published: (2013-01-01)

Bremelanotide for Treatment of Female Hypoactive Sexual Desire
by: Amber N. Edinoff, et al.
Published: (2022-01-01)

Evaluation and Management of Hypoactive Sexual Desire Disorder
by: Anita H. Clayton, MD, et al.
Published: (2018-06-01)

Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease
by: Audrey Hector, et al.
Published: (2021-01-01)

The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease.
by: Muirhead, K, et al.
Published: (2010)

Amyloid-beta and tau protein beyond Alzheimer’s disease
by: Morteza Abyadeh, et al.
Published: (2024-01-01)

Natural Products Targeting Amyloid Beta in Alzheimer’s Disease
by: Joo-Hee Lee, et al.
Published: (2021-02-01)

Optical Imaging of Beta-Amyloid Plaques in Alzheimer’s Disease
by: Ziyi Luo, et al.
Published: (2021-07-01)

The Beta Amyloid Dysfunction (BAD) Hypothesis for Alzheimer’s Disease
by: Heinz Hillen
Published: (2019-11-01)

Bone mass and bone quality are altered by hypoactivity in the chicken.
by: Eric Aguado, et al.
Published: (2015-01-01)

Hypoactive sexual desire disorder caused by antiepileptic drugs
by: M Singh, et al.
Published: (2015-01-01)

TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease
by: Francesca La Rosa, et al.
Published: (2023-05-01)

Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
by: Alejandro R Roda, et al.
Published: (2022-01-01)

Editorial: Beta-Amyloid oligomer specific treatments for Alzheimer's disease
by: Heinz Hillen
Published: (2023-01-01)

Oligodendrocytes damage in Alzheimer's disease: Beta amyloid toxicity and inflammation
by: ALEJANDRO D ROTH, et al.
Published: (2005-01-01)

Simvastatin Efficiently Reduces Levels of Alzheimer’s Amyloid Beta in Yeast
by: Sudip Dhakal, et al.
Published: (2019-07-01)

The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.
by: Stephanie J Soscia, et al.
Published: (2010-03-01)

Moving away from amyloid beta to move on in Alzheimer research
by: María Guadalupe eMoreno-Treviño, et al.
Published: (2015-01-01)

Effects of aluminum on amyloid-beta aggregation in the context of Alzheimer’s disease
by: Qiulan Zhang, et al.
Published: (2019-12-01)

Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s disease
by: Maria Luisa Moro, et al.
Published: (2018-01-01)

Hypoactive Sexual Desire Disorder - entity and therapeutic approaches: An overview
by: C. da Costa Campos, et al.
Published: (2021-09-01)

Nonconvulsive status epilepticus mimicking hypoactive delirium in an elderly patient
by: Halil Onder
Published: (2020-01-01)

Cholesterol as a key player in amyloid β-mediated toxicity in Alzheimer’s disease
by: Vladimir Rudajev, et al.
Published: (2022-08-01)

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum
by: Sheng-Min Wang, et al.
Published: (2024-03-01)

The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer’s disease: a literature review
by: Abby L. Brand, et al.
Published: (2022-12-01)

Islet amyloid polypeptide & amyloid beta peptide roles in Alzheimer’s disease: two triggers, one disease
by: Sofia Ferreira, et al.
Published: (2021-01-01)

Beta-sheet structured oligomers of Alzheimer's beta-amyloid peptide perturb phosphatidylcholine model membranes
by: de Planque, M, et al.
Published: (2006)

Smart electrochemical sensing of amyloid-beta to manage total Alzheimer’s diseases
by: Ajeet Kaushik
Published: (2024-01-01)

Development of Beta-Amyloid-Specific CAR-Tregs for the Treatment of Alzheimer’s Disease
by: Valerie Saetzler, et al.
Published: (2023-08-01)